Page d'accueil  |  Aide  |  Effacer
Anglais  |  Français
 Rechercher  |  Catégories  |  Titres A-Z  |  Pays  |  Comparer pays  |  Index  
Etendre sommaire
Document complet
Dérouler chapitre
Préférences

fermer ce livreStandard Treatment Guidelines (STG) and The National Essential Drug List for Tanzania (NEDLIT) (WHO; 1997; 210 pages)
Afficher le documentFOREWORD
Afficher le documentACKNOWLEDGMENTS
Afficher le documentINTRODUCTION
fermer ce répertoireStandard Treatment Guidelines (STG)
ouvrir ce répertoire et afficher son contenu1. GASTROINTESTINAL CONDITIONS
fermer ce répertoire2. RESPIRATORY DISEASES
fermer ce répertoire2.1 Acute Respiratory Infections (ARI)
Afficher le document2.1.1 Pneumonia
Afficher le document2.1.2 ARI in Children
Afficher le document2.1.3 Wheezing
Afficher le document2.1.4 Croup
Afficher le document2.1.5 Laryngeal Diphtheria
ouvrir ce répertoire et afficher son contenu2.1.6 ARI in Adult
Afficher le document2.1.7 Chronic Bronchitis
Afficher le document2.1.8 Other Respiratory Infections
fermer ce répertoire2.1.9 Asthma
Afficher le document2.1.9.1 Chronic Asthma in Adults
Afficher le document2.1.9.2 Moderate Asthma in Adults
Afficher le document2.1.9.3 Severe Asthma in Adults
Afficher le document2.1.9.4 Maintenance therapy in children
Afficher le document2.1.10 Cough
Afficher le document2.1.11 Whooping Cough
Afficher le document2.1.12 Allergic rhinitis
ouvrir ce répertoire et afficher son contenu3. OBSTETRIC AND GYNAECOLOGICAL CONDITIONS AND CONTRACEPTION
ouvrir ce répertoire et afficher son contenu4. CARDIOVASCULAR DISEASES
ouvrir ce répertoire et afficher son contenu5. MALARIA
ouvrir ce répertoire et afficher son contenu6. SKIN DISEASES
ouvrir ce répertoire et afficher son contenu7. SEXUALLY TRANSMITTED INFECTIONS / DISEASES (STD)
ouvrir ce répertoire et afficher son contenu8. DENTAL AND ORAL CONDITIONS
ouvrir ce répertoire et afficher son contenu9. GENITO-URINARY DISEASES: KIDNEY CONDITIONS
ouvrir ce répertoire et afficher son contenu10. EAR, NOSE AND THROAT CONDITIONS
ouvrir ce répertoire et afficher son contenu11. EYE CONDITIONS
ouvrir ce répertoire et afficher son contenu12. TUBERCULOSIS AND LEPROSY
ouvrir ce répertoire et afficher son contenu13. MUSCULOSKELETAL CONDITIONS AND JOINT DISEASES
ouvrir ce répertoire et afficher son contenu14. METABOLIC AND ENDOCRINE SYSTEM CONDITIONS
ouvrir ce répertoire et afficher son contenu15. CENTRAL NERVOUS SYSTEM DISEASE CONDITIONS
ouvrir ce répertoire et afficher son contenu16. OTHER DISEASE CONDITIONS
ouvrir ce répertoire et afficher son contenu17. VIRAL INFECTIONS
ouvrir ce répertoire et afficher son contenu18. ALLERGIC REACTIONS
ouvrir ce répertoire et afficher son contenu19. NUTRITIONAL AND HAEMATOLOGIC CONDITIONS
ouvrir ce répertoire et afficher son contenu20. MALIGNANT DISEASE CONDITIONS
ouvrir ce répertoire et afficher son contenu21. INJURIES AND TRAUMA
Afficher le document22. FOREIGN BODIES
Afficher le document23. PAIN
Afficher le document24. POISONING
Afficher le document25. NORMAL LABORATORY VALUES
ouvrir ce répertoire et afficher son contenuNATIONAL ESSENTIAL DRUG LIST
Afficher le documentABBREVIATIONS AND SYMBOLS
 
2.1.9.4 Maintenance therapy in children

Table: Asthma Maintenance therapy in Children

SEVERITY OF ASTHMA

TREATMENT

Mild Intermittent associate mainly with respiratory infections

Intermittent Treatment
Salbutamol (O) 0.15 mg/kg/day to the nearest 1 mg) in 2 to 4 divided doses
1 to 5 years: 1 to 2 mg four times a day
5 to 12 years: 2 to 4 mg four times a day
> 12 years: 4 mg four times a day
OR if available
Salbutamol inhaler intermittently

Moderate Frequent, triggered by infection, allergy, exercise etc.

Continuous Treatment
Salbutamol (O/Inhalation)as above
+/- Sodium cromoglycate Inhaler (if available) 1 mg (1 spincap) three to tour times a day. Dose may be increased to a maximum of 2 spincaps six times a day.

Severe Persistent, persistent wheeze and/or failure to

Add to the Above
Beclomethasone inhaler (50 micrograms/puff) 1 to 2 puffs three to four times a day respond to the above(always use a spacer)
OR
Prednisolone (O) 1 to 2 mg/kg/day initially, reducing to dose which controls the asthma; then attempt to give on alternative days (5 to 10 mg dose).

NOTE Long term prednisolone in children should be avoided unless there is no alternative.

Acute Attacks in Children

The same general measures apply as in adult. Give Several puffs of Salbutamol metered inhalation.

If poor response

Add

Adrenaline 1:1000 (SC) 0.01 ml/kg

OR

Aminophylline (slow IV) 4 mg/kg over 10 minutes. Do not give if oral aminophylline was given in the last 8 hours.

Unless response to the above is dramatic and complete, start:-

Prednisolone (O) 2 mg/kg/day in divided doses for 3-5 days. Severe

Acute Attack in children.

If response to the above therapy is inadequate, give

Dextrose 5% IV - 100 ml/kg/day

Plus

Aminophylline (IV infusion) at 0.8 - 1 mg/kg/hour

Plus

Hydrocortisone (IV) 2 mg/kg every 4 hours

Change to oral therapy when possible.

Prednisolone (O) 2 mg/kg/day for 5 days

Prophylaxis of asthma

Sodium cromoglycate is used in the prophylactic treatment of asthma including exercise-induced asthma. It should however, not be used for acute attacks of asthma as it has no effect on an established asthmatic attack. Sodium cromoglycate should be used regularly. When withdrawing treatment, the dose should be reduced gradually over a period of one week. Sodium cromoglycate should be used for at least 4 weeks before it can be proved as ineffective

vers la section précédentevers la section suivante

S'il vous plaît envoyez vos commentaires
Abréviations
Anglais  |  Français